These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1183 related articles for article (PubMed ID: 32171740)
1. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Devaux CA; Rolain JM; Colson P; Raoult D Int J Antimicrob Agents; 2020 May; 55(5):105938. PubMed ID: 32171740 [TBL] [Abstract][Full Text] [Related]
2. Of chloroquine and COVID-19. Touret F; de Lamballerie X Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496 [TBL] [Abstract][Full Text] [Related]
3. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2. Uzunova K; Filipova E; Pavlova V; Vekov T Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965 [TBL] [Abstract][Full Text] [Related]
4. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? Quiros Roldan E; Biasiotto G; Magro P; Zanella I Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286 [TBL] [Abstract][Full Text] [Related]
5. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221 [TBL] [Abstract][Full Text] [Related]
6. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19. Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926 [TBL] [Abstract][Full Text] [Related]
7. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus? Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115 [TBL] [Abstract][Full Text] [Related]
8. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research. Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817 [TBL] [Abstract][Full Text] [Related]
9. Chloroquine and hydroxychloroquine in covid-19. Ferner RE; Aronson JK BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046 [No Abstract] [Full Text] [Related]
10. Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy? Ibáñez S; Martínez O; Valenzuela F; Silva F; Valenzuela O Clin Rheumatol; 2020 Aug; 39(8):2461-2465. PubMed ID: 32495226 [TBL] [Abstract][Full Text] [Related]
11. Chloroquine and its derivatives in the management of COVID-19: A scoping review. Pimentel J; Andersson N Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192 [TBL] [Abstract][Full Text] [Related]
12. Chloroquine for COVID-19: rationale, facts, hopes. Cortegiani A; Ippolito M; Ingoglia G; Einav S Crit Care; 2020 May; 24(1):210. PubMed ID: 32384908 [No Abstract] [Full Text] [Related]
13. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Wang M; Cao R; Zhang L; Yang X; Liu J; Xu M; Shi Z; Hu Z; Zhong W; Xiao G Cell Res; 2020 Mar; 30(3):269-271. PubMed ID: 32020029 [No Abstract] [Full Text] [Related]
14. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine. de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793 [TBL] [Abstract][Full Text] [Related]
15. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic. Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198 [TBL] [Abstract][Full Text] [Related]
16. Insights from nanomedicine into chloroquine efficacy against COVID-19. Hu TY; Frieman M; Wolfram J Nat Nanotechnol; 2020 Apr; 15(4):247-249. PubMed ID: 32203437 [TBL] [Abstract][Full Text] [Related]
17. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Yao X; Ye F; Zhang M; Cui C; Huang B; Niu P; Liu X; Zhao L; Dong E; Song C; Zhan S; Lu R; Li H; Tan W; Liu D Clin Infect Dis; 2020 Jul; 71(15):732-739. PubMed ID: 32150618 [TBL] [Abstract][Full Text] [Related]
18. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals. Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586 [TBL] [Abstract][Full Text] [Related]
19. Is hydroxychloroquine beneficial for COVID-19 patients? Li X; Wang Y; Agostinis P; Rabson A; Melino G; Carafoli E; Shi Y; Sun E Cell Death Dis; 2020 Jul; 11(7):512. PubMed ID: 32641681 [TBL] [Abstract][Full Text] [Related]
20. Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population. Yao X; Hou Z; Cui C; Zhang M; Tu S; Li H; Liu D Curr Drug Metab; 2020; 21(7):534-540. PubMed ID: 32651961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]